Director Carley Brian T sold 4,003 shares of MEDP at $345.59 on 2025-02-24; holds 26,032 post-sale.
Director Carley Brian T executed a sale of 4,003 shares (–13.3% vs pre-transaction holdings) at $345.59, reducing his stake to 26,032 shares. The transaction occurred when MEDP trades 25.8% below its 52-week high of $457.29 and 1.8% above its 52-week low of $308.93, placing the sale near the lower half of the annual range. The company remains fundamentally sound with 11.8% annual revenue growth, net income of $96.4M on revenue of $533.3M, and a reasonable P/E of 21.23; however, the director's reduction in absolute share count after a stock decline warrants disclosure review to understand the sale's timing and motivation in relation to company outlook or personal portfolio management.